-isomer is largely inactive, the therapeutic significance of the isomer delivery is likely to get negligible.On top of that, provided the shifting nature of costs for a variety of stimulant formulations as determined by the insurer, pharmacy Gains manager, and/or pharmacy, it continues to be hard to the individual and clinician to make treatment ch